Quinoxaline 1 :4 di-N-oxide (RD 2579) was first described by McIlwain (1943) , who drew attention to its bacteriostatic action against Streptococcus haemolyticus and Corynebacterium diphtheriae in in vitro tests. Later Frisk (1946) showed that it possessed tuberculostatic activity, and more recently Jones, Landquist, and Stewart (1953) reported amoebicidal properties, and made incidental reference to its activity against Gram-negative bacteria. Hurst, Landquist, Melvin, Peters, Senior, Silk, and Stacey (1953) found it effective in the therapy of experimental psittacosis and lymphogranuloma venereum (inguinale) .
A sample of RD 2579 was supplied by Dr. W. F. Short in August, 1952 . We were impressed by its action against Gram-negative bacteria, and particularly by the fact that not only was it bacteriostatic for Salmonellae, Shigellae, and coliforms, but also for each of thirteen strains of Pseudomonas pyocyanea and of eleven strains of Proteus vulgaris against which it was tested. This activity was maintained virtually undiminished in bloodcontaining media.
METHODS
In vitro Tests.-Dilutions in papain digest broth showed that RD 2579 inhibits growth of Gramnegative bacteria at concentrations of about 0.01 to 0.003%.
In vivo-In vitro Tests.-The antibacterial activity of RD 2579 in mice was investigated by a modification of the method described by Croshaw and Foley (1954) .
The drug was administered to groups of mice and these were sacrificed at intervals. The Albino mice were used throughout and in any one experiment all were of the same sex and strain and, as far as possible, of the same weight. This was usually 25-30 g. RESULTS Table I shows typical results of a number of in viva-in vitro tests against a variety of Gramnegative bacteria. The serum of treated mice remained bacteriostatic for at least 2 hr. after an intraperitoneal dose of RD 2579. On the basis of in vitro bacteriostatic titres of RD 2579 and streptomycin with strains " YDE," " Kilner " and " Sinclair," protection tests were carried out in mice. Eighteen mice were used in each test, and each was infected with 0.2 ml. of a 1 in 5 dilution of an 18 hr. broth culture by injection in the left thigh muscle. Two hours after infection six mice were given RD 2579 (250 mg./ kg.) subcutaneously, six received streptomycin (125 mg. /kg.) also subcutaneously, and six remained untreated. The size of the local lesion was measured in each survivor 24 hr. after infection by deducting the width of the normal thigh from that of the affected thigh. Table III shows the results obtained in these tests by Professor Selbie. By M. R. GURD The main toxic effect of RD 2579 given systemically is on the liver and kidneys (Jones et al., 1953) .
In our rats, repeated oral doses of 200 mg. /kg. daily caused severe cellular degeneration in the liver and less severe damage to the kidneys. Daily oral doses of 50 mg./ kg. caused mild liver damage, without discernible damage to the kidneys. When administered subcutaneously mild toxic effects such as inhibition of growth were noted with doses as low as 6 mg. /kg. daily.
The compound had little or no irritant effect when injected intrathecally or into the anterior chamber of the eye. The toxicity to leucocytes was also low.
